Fetal Alcohol Spectrum Disorders

Research in Fetal Alcohol Spectrum Disorders (FASD) investigates the complex effects of prenatal alcohol exposure on brain development and function. This work explores the underlying biological mechanisms, including neuroinflammation, neurodegeneration, and altered neural connectivity, using a combination of animal models and cellular studies. Investigations also focus on identifying biomarkers for early diagnosis, understanding the long-term behavioral and cognitive consequences, and developing effective interventions and treatments. Research spans basic science inquiries into how alcohol impacts developing neurons and glial cells to translational studies aimed at improving clinical outcomes for affected individuals.

Given Arkansas's demographics and public health landscape, research into FASD holds significant relevance. Understanding the prevalence and impact of FASD can inform public health strategies and resource allocation within the state. This work contributes to improving developmental outcomes for children and supporting families, addressing a critical need within Arkansas communities. The research also has implications for healthcare providers and educators across the state.

This area of study draws upon expertise in neuroscience, pharmacology, immunology, and developmental biology. Collaborations extend to researchers examining substance abuse, maternal and perinatal health, and disease modeling, fostering a comprehensive approach to understanding and addressing FASD.